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	 Oximes	and	nitrate	esters	are	considered	as	important	nitric	oxide	(NO)	donors	with	diverse
biological	activities.	Herein,	we	report	the	synthesis	and	characterization	of	new	oxime	and
nitrate	 ester	 derivatives	 of	 norfloxacin	 as	 potential	 NO	 donor	 hybrids	 with	 expected
synergistic	antimicrobial	activity.	The	release	of	NO	from	those	hybrids	was	measured	by	a
modified	Griess	method	in	which	p‐nitroaniline	was	employed	instead	of	sulfanilamide.	The
increased	 electrophilicity	 of	 the	 intermediate	4‐nitroaniline	diazonium	salt	 accelerated	 the
coupling	process	and	shortened	the	overall	assessment	time.	The	improved	detection	limits
and	 enhanced	 sensitivity	would	 pave	 the	way	 for	 the	 future	 application	 of	 this	method	 in
nitrite	determination	in	biological	or	non‐biological	systems.	
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1.	Introduction	
	
Nitric	oxide	is	a	key	signalling	molecule	regulating	various	
physiological	 functions	 such	 as	 platelet	 aggregation	 [1],	
vascular	 tone	 [2,3],	 immune	response	and	neurotransmission	
[4‐8].	 Likewise,	 numerous	 reports	 demonstrated	 the	 signifi‐
cance	 of	 NO	 in	 mediating	 the	 antiproliferative,	 antibacterial,	
antiviral	 and	 antiprotozoal	 properties	 of	 activated	 macro‐
phages	[9,10].	
Given	 the	 aforementioned	 diverse	 and	 important	 physio‐
logical	 roles	 of	 NO	 and	 considering	 the	 difficulty	 of	 handling	
NO	as	a	gas,	a	great	research	interest	has	been	directed	to	the	
modulation	 of	 NO	 in	 physiological	 systems	 by	 increasing	 its	
concentration	through	exogenous	release	by	NO	donors.	Such	
NO	 progenitors	 have	 now	 received	 great	 attention	 as	
promising	 candidates	 for	 the	 treatment	 of	 various	 diseases	
associated	 with	 NO‐based	 cellular	 activities	 [11,12].	 In	 this	
regard,	 various	 classes	 of	NO	donors	 have	 been	 identified	 as	
organic	 nitrates	 and	 nitrites,	 S‐nitrosothiols,	 sydnonimines,	
metal	 nitrosyls,	 furoxans,	 diazeniumdiolates	 and	 oximes.	 Of	
particular	 significance	 is	 the	 proven	 clinical	 implication	 of	
organic	nitrates	as	glyceryl	trinitrate,	isosorbide	dinitrate	and	
isosorbide	 mononitrate	 as	 primary	 antianginal	 medications	
[13].	
It	 is	 generally	 accepted	 that	 the	 therapeutic	 potential	 of	
the	NO	donors	largely	depends	on	their	ability	to	release	NO	in	
the	 biological	 systems.	 In	 order	 to	 correlate	 the	 NO	 release	
with	 biological	 effects,	 it	 is	 important	 to	 estimate	 NO	
concentrations	 generated	 from	NO	 donors	 in	 vitro	as	well	 as	
the	 time	 course	 of	 the	 NO	 production.	Generally,	 various	
methods	 have	 been	 utilized	 to	 analyze	 NO	 release	 from	 NO	
donors.	 NO	 can	 be	 estimated	 by	 gas	 chromatography‐mass	
spectrometry	[14],	chemiluminescence	[15],	or	by	fluorescent	
probes	 such	 as	 4,5‐diaminofluorescein	 [16],	 laser	 magnetic	
resonance	 spectroscopy	 [17],	 electrochemical	 methods	 [18]	
and	capillary	 electrophoresis	with	 laser	 induced	 fluorescence	
detection	 [19].	 In	 addition,	 Griess	 colorimetric	 assay	 [20,21]	
and	 its	 modifications	 [22,23]	 represent	 the	 most	 commonly	
used	methods	for	 the	analysis	of	NO	 in	view	of	 the	simplicity	
and	 low	cost.	The	method	relies	on	 indirect	determination	of	
NO	 via	 spectrophotometric	 measurement	 of	 its	 stable	
decomposition	product	NO2.	The	reaction	involves	two	steps;	
the	 first	 step	 is	 the	 reaction	 of	 dinitrogen	 trioxide,	 resulting	
from	the	auto	oxidation	of	NO,	with	sulfanilamide	to	produce	a	
diazonium	 ion.	The	 second	 step	 is	 the	 coupling	of	 diazonium	
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ion	 with	 N‐(1‐naphthyl)ethylenediamine	 (NED)	 to	 form	 a	
coloured	 azo	 dye	 that	 absorbs	 at	 max	 546	 nm.	 Despite	 the	
feasibility	 of	 the	 method,	 it	 sometimes	 suffers	 from	 poor	
sensitivity	 and	 inferior	 reproducibility	 at	 submicromolar	
concentrations	of	NO.	
In	 continuation	 of	 our	 efforts	 to	 discover	 new	 NO‐based	
drug	 candidates,	 the	 present	work	 aims	 at	 the	 synthesis	 and	
characterization	 of	 new	 norfloxacin/NO	 donor	 hybrids	 with	
potential	 synergistic	 antimicrobial	 properties.	 The	 release	 of	
NO	 from	 the	 prepared	 hybrids	 is	 estimated	 by	 adapting	 a	
modification	 to	 the	 common	 Griess	 method	 with	 a	 view	 to	
enhancing	the	sensitivity	and	shortening	the	assessment	time.	
	
2.	Experimental	
	
2.1.	Instrumentations	
	
All	chemicals	and	solvents	used	for	the	preparation	of	the	
intermediates	 and	 target	 compounds	 were	 purchased	 from	
commercial	 resources	 and	 used	 without	 purification.	 The	
reaction	progress	was	monitored	using	TLC	(Kieselgel	60	F254	
pre‐coated	 plates,	 E.	 Merck,	 Darmstadt,	 Germany)	 and	 the	
spots	were	detected	by	exposure	to	UV	lamp	at	λ	254	and	365	
nm.	Melting	points	were	determined	on	Stuart	electrothermal	
melting	 point	 apparatus	 and	 were	 uncorrected.	 IR	 spectra	
were	 recorded	 as	 KBr	 disks	 on	 SHIMADZU	 IR‐470	 spectro‐
photometer,	 at	 the	 Central	 Laboratory,	 Faculty	 of	 Science,	
Sohag	University.	NMR	spectra	(400	MHz	for	1H,	100	MHz	for	
13C)	were	 recorded	on	 a	BRUKER	Avance	 III	 spectrometer	 at	
the	 Faculty	 of	 Science,	 Sohag	 University,	 using	 TMS	 as	 an	
internal	standard	and	CDCl3	or	DMSO‐d6	as	solvents.	Chemical	
shifts	(δ)	values	are	expressed	in	parts	per	million	(ppm)	and	
coupling	constants	(J)	in	Hertz	(Hz).	The	signals	are	designated	
as	 follows:	 s,	 singlet;	 d,	 doublet;	 t,	 triplet;	 q,	 quartet;	 m,	
multiplet;	 brs,	 broad	 singlet.	 Elemental	 microanalysis	 was	
carried	 out	 in	 Al‐Azhar	University	 at	 the	 Regional	 Centre	 for	
Mycology	 and	 Biotechnology.	 High	 resolution	 mass	 spectra	
were	recorded	on	Thermo	Scientific	Q	Exactive	Orbitrap	mass	
spectrometer,	 Faculty	 of	 Pharmaceutical	 Sciences,	 University	
of	British	Columbia,	Vancouver,	Canada.	
	
2.2.	Synthesis	
	
2.2.1.	Synthesis	of	7‐(4‐(2‐bromoacetyl)	piperazin‐1‐yl)‐1‐
ethyl‐6‐fluoro‐1,4‐dihydro‐4‐oxoquinoline‐3‐carboxylic	acid	
(2)	
	
To	a	stirred	solution	of	norfloxacin	(0.319	g,	1.0	mmol)	in	
dichloromethane	 (50	mL)	was	added	a	solution	of	potassium	
carbonate	(0.152	g,	1.1	mmol)	in	distilled	water	(50	mL)	at	0‐5	
°C.	 Then,	 bromoacetyl	 bromide	 (0.22	 g,	 1.1	 mmol)	 in	
dichloromethane	 (25	mL)	was	slowly	added	over	 a	period	of	
30	min.	Stirring	was	continued	for	2	h	at	0‐5	°C,	then	at	room	
temperature	for	additional	12	h.	The	whole	mixture	was	then	
transferred	to	a	separatory	funnel	where	it	was	extracted	with	
dichloromethane	 and	 washed	 successively	 with	 1.0	 N	 HCl	
(2×25	 mL)	 and	 water	 (2×25	 mL).	 The	 organic	 layer	 was	
separated,	dried	over	anhydrous	sodium	sulphate,	filtered	and	
evaporated	under	 reduced	pressure	 to	give	compound	2	 in	a	
sufficiently	 pure	 form	 suitable	 for	 use	 in	 the	 next	 reaction	
without	further	purification	(Scheme	1).	Color:	White	powder.	
Yield:	 0.370	 g	 (84%).	M.p.:	 247‐249	 °C.	 FT‐IR	 (KBr,	 ν,	 cm‐1):	
1713	(carboxylic	C=O),	1666	(amidic	C=O),	1620	(4‐keto	C=O).	
1H	NMR	(400	MHz,	DMSO‐d6,	 δ,	ppm):	1.45	 (t,	3H,	 J	=	7.6	Hz,	
NCH2CH3),	3.38‐3.42	(m,	4H,	piperazinyl‐H),	3.70‐3.74	(m,	4H,	
piperazinyl‐H),	4.20	(s,	2H,	BrCH2),	4.59	(q,	2H,	J	=	7.6	Hz,	NCH‐
2CH3),	7.22	(d,	1H,	JH‐F	=	7.6	Hz,	H8),	7.96	(d,	1H,	JH‐F	=	13.6	Hz,	
H5),	8.94	(s,	1H,	H2),	15.22	(s,	1H,	COOH).	13C	NMR	(100	MHz,	
DMSO‐d6,	 δ,	 ppm):	 14.86,	 28.29,	 41.76,	 46.11,	 49.56,	 106.86,	
107.58,	 111.73	 (d,	 J	 =	 23	 Hz),	 120.06	 (d,	 J	 =	 8	 Hz),	 137.62,	
145.56	 (d,	 J	=	11	Hz),	149.14,	153.29	(d,	 J	=	247	Hz),	165.49,	
166.57,	 176.67.	 Anal.	 calcd.	 for	 C18H19BrFN3O4:	 C,	 49.11;	 H,	
4.35;	N,	9.54.	Found:	C,	49.34;	H,	4.31;	N,	9.78%.	
	
2.2.2.	Synthesis	of	1‐ethyl‐6‐fluoro‐7‐((4‐(2‐nitrooxy)acetyl)	
piperazin‐1‐yl)‐4‐oxo‐1,4‐dihydroquinoline‐3‐carboxylic	
acid	(3)	
	
To	 a	 stirred	 solution	 of	 bromide	2	 (0.44	 g,	 1.0	mmol)	 in	
acetonitrile	(10	mL),	sliver	nitrate	(4	mmol)	in	acetonitrile	(10	
mL)	was	added	portion	wise	and	 the	mixture	was	heated	 for	
16	 h	 at	 80	 °C.	 The	 formed	 precipitate	 of	 silver	 bromide	was	
filtered	 off,	 and	 the	 filtrate	 was	 evaporated	 till	 dryness,	
dissolved	 in	 dichloromethane	 (30	 mL)	 and	 washed	 with	
distilled	water	 (2×25	mL)	 and	 brine	 (2×25	mL).	 The	 organic	
layer	 was	 dried	 over	 anhydrous	 sodium	 sulfate,	 filtered	 and	
concentrated	 under	 reduced	 pressure.	 The	 residue	 was	
crystallized	 from	 acetonitrile	 to	 give	 nitrate	 ester	3	 (Scheme	
1).	 Color:	 Yellow	 crystals.	 Yield:	 0.177	 g	 (41.9%).	 M.p.:	 201‐
203	 °C.	 FT‐IR	 (KBr,	 ν,	 cm‐1):	 1715	 (carboxylic	 C=O),	 1668	
(amidic	C=O),	1623	(4‐keto	C=O).	1H	NMR	(400	MHz,	DMSO‐d6,	
δ,	 ppm):	 1.45	 (t,	 3H,	 J	 =	 7.6	 Hz,	 CH2CH3),	 3.35‐3.45	 (m,	 4H,	
piperazinyl‐H),	3.61‐3.71	(m,	4H,	piperazinyl‐H),	4.59	(q,	2H,	J	
=	7.6	Hz,	CH2CH3	),	5.46	(s,	2H,	CH2ONO2),	7.22	(d,	1H,	JH‐F	=	6.8	
Hz,	H8),	7.96	(d,	1H,	JH‐F	=	13.6	Hz,	H5),	8.94	(s,	1H,	H2),	15.23	
(s,	 1H,	 COOH).	 13C	NMR	 (100	MHz,	DMSO‐d6,	 δ,	 ppm):	 14.76,	
41.61,	44.00,	49.54,	50.03,	69.32,	106.70,	107.76,	111.79	(d,	J	=	
23	Hz),	120.09,	137.70,	145.54,	148.98,	153.29	(d,	J	=	248	Hz),	
163.97,	 166.44,	 167.71.	 HRMS	 (ESI,	 m/z)	 calcd.	 for	
C18H18FN4O7	[M‐H]¯:	421.11650,	found:	421.11700.	
	
2.2.3.	Synthesis	of	N‐(4‐acetylphenyl)‐3‐bromopropan	
amide	(5)	
	
To	a	stirred	solution	of	p‐aminoacetophenone	(4)	(0.675	g,	
5.0	mmol)	 in	dichloromethane	(30	mL)	was	added	a	solution	
of	potassium	carbonate	(0.76	g,	5.5	mmol)	in	water	(30	mL)	at	
0‐5	°C.	Then,	3‐bromopropionyl	chloride	(0.94	g,	5.5	mmol)	in	
dichloromethane	 (30	mL)	was	 slowly	added	over	 a	period	of	
30	min.	Stirring	was	continued	for	2	h	at	0‐5	°C,	then	at	room	
temperature	for	additional	12	h.	The	whole	mixture	was	then	
transferred	to	a	separatory	funnel	where	it	was	extracted	with	
dichloromethane	 and	 washed	 with	 water	 (2×25	 mL).	 The	
organic	 layer	 was	 separated,	 dried	 over	 anhydrous	 sodium	
sulphate,	filtered	and	evaporated	under	reduced	pressure.	The	
residue	was	crystallized	from	95%	ethanol	to	give	bromide	5	
in	a	sufficiently	pure	form	suitable	for	use	in	the	next	reaction	
without	further	purification	(Scheme	1).	Color:	White	crystals.	
Yield:	 1.25	 g	 (93%).	 M.p:	 175‐176	 °C.	 FT‐IR	 (KBr,	 ν,	 cm‐1):	
3323	 (NH),	 1692	 (NHCOCH2),	 1654	 (COCH3).	 1H	 NMR	 (400	
MHz,	CDCl3,	δ,	ppm):	2.61	(s,	3H,	COCH3),	3.00	(t,	2H,	J	=	8.0	Hz,	
CH2CH2Br),	3.73	(t,	2H,	 J	=	8.0	Hz,	CH2CH2Br),	7.64	(d,	2H,	 J	=	
8.8	 Hz,	 Ar‐H),	 7.96	 (d,	 2H,	 J	 =	 8.8	 Hz,	 Ar‐H),	 10.70	 (s,	 1H,	
NHCO).	
	
2.2.4.	Synthesis	of	7‐(4‐(3‐((4‐acetylphenyl)amino)‐3‐oxo	
propyl)piperazin‐1‐yl)‐1‐ethyl‐6‐fluoro‐4‐oxo‐1,4‐dihydro	
quinoline‐3‐carboxylic	acid	(6)	
	
To	a	stirred	solution	of	compound	5	(0.297	g,	1.1	mmol)	in	
acetonitrile	 (10	 mL)	 was	 added	 norfloxacin	 (0.319	 g,	 1.0	
mmol).	Then,	triethyamine	(0.202	g,	2.0	mmol)	was	added	and	
the	 mixture	 was	 heated	 under	 reflux	 for	 18	 h.	 The	 formed	
precipitate	 was	 filtered	 while	 hot,	 washed	 with	 acetonitrile	
and	 dried	 under	 vacuum	 to	 give	 compound	 6	 (Scheme	 1).	
Color:	White	powder.	Yield:	0.274	g	 (54%).	M.p.:	275‐276	 °C.	
FT‐IR	 (KBr,	 ν,	 cm‐1):	 3271(NH),	 1725	 (carboxylic	 C=O),	 1675	
(amidic	 C=O),	 1652	 (CH3C=O),	 1617	 (4‐keto	 C=O).	 1H	 NMR	
(400	MHz,	DMSO‐d6,	δ,	ppm):	1.44	(t,	3H,	J	=	7.6	Hz,	NCH2CH3),	
2.52	 (s,	 3H,	 COCH3),	 2.59	 (t,	 2H,	 J	 =7.6	 Hz,	 COCH2CH2),	 2.65‐
2.68	(m,	4H,	piperazinyl‐H),	2.78	(t,	2H,	J	=	7.6	Hz,	COCH2CH2),	
3.34‐3.42	(m,	4H,	piperazinyl‐H),	4.58	(q,	2H,	J	=	7.6,	NCH2CH3),		
Aziz	et	al.	/	European	Journal	of	Chemistry	8	(2)	(2017)	119‐124	 121	
 
	
 
Scheme	1	
	
	
7.18	 (d,	1H,	 JH‐F	=	7.6	Hz,	H8),	 7.73	 (d,	2H,	 J	 =	8.8	Hz,	Ar‐	H),	
7.91‐7.93	 (m,	3H,	Ar‐2H	+	H5),	8.91	 (s,	1H,	H2),	10.28	 (s,	1H,	
NHCO),	15.22	(s,	1H,	COOH).	 13C	NMR	(100	MHz,	DMSO‐d6,	δ,	
ppm):	14.74,	26.76,	34.80,	49.49,	50.01,	52.63,	53.92,	106.25,	
107.69,	111.65	 (d,	 J	 =	23Hz),	 118.85,	119.78,	129.85,	132.23,	
137.75,	143.99,	145.95,	148.84,	153.37	(d,	J	=	247	Hz),	166.48,	
171.14,	 176.67,	 196.81.	 HRMS	 (ESI,	 m/z)	 calcd.	 for	
C27H28FN4O5	[M‐H]:	507.20492,	found:	507.20514.	
	
2.2.5.	Synthesis	of	(E)‐1‐cyclopropyl‐6‐fluoro‐7‐(4‐(3‐((4‐(1‐
(hydroxyimino)ethyl)phenyl)amino)‐3‐oxopropyl)pipera	
zin‐1‐yl)‐4‐oxo‐1,4‐dihydroquinoline‐3‐carboxylic	acid	(7)	
	
To	a	stirred	suspension	of	the	ketone	6	(0.508	g,	1.0	mmol)	
in	 absolute	 ethanol	 (10	 mL)	 were	 added	 hydroxylamine	
hydro‐chloride	 (0.278	 g,	 4.0	 mmol)	 and	 anhydrous	 sodium	
acetate	 (0.328	 g,	 4.0	 mmol).	 The	 mixture	 was	 heated	 under	
reflux	for	12	h.	The	formed	precipitate	was	filtered	while	hot,	
washed	with	ethanol,	dried	and	crystallized	 from	acetonitrile	
to	 afford	 oxime	 7	 (Scheme	 1).	 Color:	 White	 crystals.	 Yield:	
0.334	g	(65.8	%).	M.p.:	290‐292	°C.	FT‐IR	(KBr,	ν,	cm‐1):	1679	
(carboxylic	 C=O),	 1627	 (4‐keto	 C=O),	 1601	 (C=N).	 1H	 NMR	
(400	MHz,	DMSO‐d6,	δ,	ppm):	1.43	(t,	3H,	J	=	7.6	Hz,	NCH2CH3),	
2.13	(s,	3H,	CH3C=NOH),	2.55	(t,	2H,	J	=	7.6	Hz,	NHCOCH2CH2),	
2.63‐2.71	 (m,	 4H,	 piperazinyl‐H),	 2.76	 (t,	 2H,	 J	 =	 7.6	 Hz,	
NHCOCH2CH2),	 3.33‐3.41	 (m,	 4H,	 piperazinyl‐H),	 4.58	 (q,	 2H,					
J	=	7.6	Hz,	NCH2CH3),	7.18	(d,	1H,	JH‐F	=	7.6	Hz,	H8),	7.60	(m,	4H,	
Ar‐H	),	7.91	(d,	1H,	JH‐F	=	13.6	Hz,	H5),	8.92	(s,	1H,	H2),	10.06	(s,	
1H,	 NHCO),	 10.94	 (s,	 1H,	 C=NOH),	 15.27	 (s,	 1H,	 COOH).	 13C	
NMR	(100	MHz,	DMSO‐d6,	δ,	ppm):	11.80,	14.76,	34.69,	49.50,	
50.01,	 52.63,	 54.06,	 106.27,	 107.65,	 111.64	 (d,	 J	 =	 23Hz),	
119.51	(d,	J	=	49	Hz),	126.43,	129.87,	132.20,	137.73,	140.06,	
145.96,	148.85,	153.38	(d,	J	=	246	Hz),	166.50,	170.61,	176.65.	
HRMS	 (ESI,	 m/z)	 calcd.	 for	 C27H29FN5O5	 [M‐H]¯:	 522.21582,	
found:	522.21606.	
	
2.3.	In	vitro	determination	of	nitric	oxide	release	
	
2.3.1.	Materials	and	methods	
	
All	 measurements	 were	 carried	 out	 using	 UV‐visible	
spectrophotometer	 (Implen	 nanophotometer,	 Germany).	
Nitrite	stock	aqueous	solution	(0.1	M	sodium	nitrite	in	water)	
was	prepared	 from	which	 a	 dilute	 solution	of	 100	μM	nitrite	
solution	was	prepared	by	diluting	1	ml	of	the	stock	solution	to	
1000	ml	with	phosphate	buffer	of	pH	=	7.4.	Working	standard	
solutions	 containing	 different	 concentrations	 of	 the	 nitrite	
(100,	 50,	 25.00,	 12.50,	 6.25,	 3.125,	 1.56,	 0.78	 and	 0.39	 μM)	
were	 prepared	 by	 further	 dilution	 of	 the	 later	 solution	 with	
phosphate	 buffer.	 The	 tested	 compounds	 were	 dissolved	 in	
DMF	 and	 diluted	 with	 the	 buffer	 system	 to	 afford	 a	
concentration	 of	 100	 μM.	 N‐Acetyl	 cysteine	 solution	 was	
prepared	in	a	concentration	of	500	μM	in	methanol.	
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Figure	1.	Resonance	stabilization	and	increased	diazonium	cations'	electrophilicity	by	electron‐withdrawing	substituents.	
	
	
The	modified	Griess	 reagent	 consists	 of	 0.1%	 (w:v)	N‐(1‐
naphthyl)ethylenediamine	 (NED)	 solution	 in	 water	 and	 4‐
nitroaniline	 solution	 (0.5%	 w:v	 of	 4‐nitroaniline	 in	 5%	 w:v	
phosphoric	acid).	
	
2.3.2.	Preparation	of	nitrite	standard	curve	
	
An	aliquot	of	100	μL	of	4‐nitroaniline	solution	was	added	
to	 the	working	 standard	nitrite	 solution.	After	 1	minute,	 100	
μL	 of	 the	 NED	 solution	 was	 added	 and	 absorbance	 of	 the	
formed	purple	 colour	was	measured	after	10	minutes	at	max	
539	nm.	A	blank	 experiment	was	performed	under	 the	 same	
conditions.	The	procedure	was	 repeated	 three	 times	 for	each	
concentration	 of	 the	 nitrite	 and	 the	 average	 absorbance	was	
calculated.	The	calibration	 curve	was	 constructed	by	plotting	
the	 average	 absorbance	 value	 against	 the	 corresponding	
nitrite	concentration.	
	
2.3.3.	NO	release	assay		
	
Solutions	 of	 the	 tested	 compounds	3	 and	7	 in	DMF	were	
diluted	 with	 phosphate	 buffer	 of	 pH	 =	 7.4	 to	 give	 a	 final	
concentration	 of	 100	 μM	 (test	 solutions).	 To	 100	 μL	 of	 each	
test	solutions,	100	μL	of	N‐acetyl	cysteine	solution	was	added	
and	 the	 obtained	 solution	was	 kept	 in	 an	 incubator	 at	 37	 C	
(treated	solutions).	The	solutions	were	treated	similarly;	as	for	
nitrite	standard	solution;	with	100	μL	of	4‐nitroaniline.	Then,	
we	just	waited	for	one	minute	after	adding	4‐nitroaniline	and	
for	 additional	 10	 minute	 after	 adding	 NED	 reagent	 and	 the	
absorbance	were	as	recorded	at	max	539	nm	every	10	minutes	
over	 a	 period	 of	 one	 hr.	 A	 blank	 experiment	was	 performed	
under	the	same	conditions,	the	procedure	was	repeated	three	
times	 for	 each	 tested	compound	and	 the	average	absorbance	
was	calculated.	The	corresponding	concentration	of	nitrite	was	
determined	by	comparison	 to	 the	nitrite	standard	calibration	
curve	 and	 the	 amount	 of	 NO	 released	 (revealed	 by	 the	
corresponding	 nitrite	 concentration)	 was	 calculated	 as	
percentage	 of	 moles	 of	 NO	 released	 from	 1	 mole	 of	 tested	
compound.	
	
3.	Results	and	discussion		
	
3.1.	Synthesis	of	norfloxacin‐NO	donor	hybrids	
	
The	 synthesis	 of	 the	 target	 hybrids	 3	 and	 7	 (Scheme	 1)	
commenced	with	 the	 base‐promoted	 acylation	 of	 norfloxacin	
(1)	 with	 bromoacetyl	 bromide	 followed	 by	 treating	 the	
resultant	bromide	2	with	silver	nitrate	 to	afford	nitrate	ester	
3.	 The	 IR	 spectrum	 of	 nitrate	 ester	 3	 showed	 asymmetric	
stretching	 band	 of	 ONO2	 at	 1544	 cm‐1	 and	 symmetric	
stretching	at	1294	cm‐1.	Comparison	of	1H	NMR	spectra	of	the	
prepared	 nitrate	 ester	 3	 with	 its	 corresponding	 bromide	 2	
showed	that	replacement	of	bromine	in	compound	2	by	nitrate	
in	 compound	 3	 leads	 to	 a	 remarkable	 downfield	 shift	 of	
methylene	CH2ONO2	protons	by	δ	1.26	ppm,	13C	NMR	spectrum	
of	compound	3	showed	shift	of	carbon	by	δ	41.03	ppm	due	to	
replacement	of	bromine	with	ONO2.	
Alkylation	of	norfloxacin	(1)	with	alkyl	halide	5;	generated	
from	 the	 reaction	 of	 p‐aminoacetophenone	 (4)	 with	 3‐
bromopropionyl	 chloride;	 afforded	 the	 corresponding	 ketone	
intermediate	 6	 that	 was	 treated	 with	 hydroxylamine	
hydrochloride	to	deliver	the	target	oxime	7.	The	structures	of	
the	target	oxime	7	and	its	corresponding	ketone	intermediate	
6	 were	 unambiguously	 confirmed	 by	 various	 spectroscopic	
tools.	 In	 addition	 to	 the	 basic	 skeleton	 of	 norfloxacin,	 the	
ketone	 intermediate	6	 showed	 additional	 pair	 of	 doublets	 in	
the	aromatic	region	at	δ	7.73	ppm	and	at	7.92	ppm	related	to	
p‐aminoacetophenone	 and	 two	 singlet	 peaks	 at	 δ	 10.28	 ppm	
(related	to	NH	proton)	and	at	δ	2.52	ppm	(related	to	COCH3).	
Moreover,	the	appearance	of	two	triplet	signals	at	δ	2.59	ppm	
and	 at	 δ	 2.78	 ppm	 related	 to	 (NHCOCH2CH2N)	 further	
confirmed	 the	 formation	 of	 ketone	 intermediate	 6.	 13C	 NMR	
and	 HRMS	 were	 additional	 evidences	 for	 the	 formation	 of	
compounds	 6.	 The	 conversion	 of	 the	 ketone	 intermediate	 6	
into	 oxime	 7	 was	 confirmed	 by	 IR,	 1H	 NMR,	 13C	 NMR	 and	
HRMS.	The	IR	spectrum	of	compound	7	showed	disappearance	
of	ketonic	carbonyl	(COCH3)	due	to	its	conversion	to	ketoxime	
group	 (C=N‐OH).	 1H	 NMR	 spectrum	 of	 compound	 7	 was	
characterized	by	the	appearance	of	new	singlet	signal	at	about	
δ	10.94	ppm	assigned	to	OH	of	the	oxime,	and	a	singlet	signal	
for	CH3C=NOH	that	was	up‐field	shifted	by	δ0.38	ppm	from	the	
original	CH3	of	 the	ketone	precursor	6.	 13C	NMR	spectrum	of	
compound	 7	 showed	 the	 disappearance	 of	 the	 ketonic	
carbonyl	 (COCH3)	 due	 its	 conversion	 to	 ketoxime	 group	
(C=NOH)	 which	 appeared	 at	 δ	 152.91	 ppm.	 Moreover,	 the	
methyl	of	(CH3C=NOH)	appeared	at	δ	11.80	ppm	with	up‐field	
shifting	by	δ	15	ppm	from	 the	original	CH3C=O	 in	 the	ketone	
precursor	6.	
	
3.2.	NO	release	measurement	
	
Our	 next	 task	 was	 to	 estimate	 the	 ability	 of	 NO	 donor	
hybrids	3	and	7	 to	 release	NO.	Disappointingly,	we	could	not	
detect	measurable	amounts	of	NO	from	our	compounds	by	the	
conventional	 Griess	 method.	 In	 an	 effort	 to	 overcome	 the	
problem,	we	adapted	a	modification	 to	 the	Griess	method	by	
replacing	 sulphanilamide	 with	 4‐nitroaniline	 aiming	 to	
enhance	 the	 sensitivity	 of	 NO	 measurement.	 We	 envisioned	
that	 the	 transiently	 generated	 NO2‐	 requires	 immediate	
capturing	 by	 an	 appropriate	 aromatic	 amine	 that	 would	
generate	 a	 highly	 reactive	 diazonium	 salt	 before	 the	 nitrous	
acid	undergoes	decomposition.	The	presence	of	nitro	group	in	
para	position	to	the	diazonium	group,	by	virtue	of	its	powerful	
electron‐withdrawing	 and	 resonance	 properties,	 would	
potentially	 enhance	 the	 electrophilicity	 of	 the	diazonium	 salt	
[24]	(Figure	1)	and	accelerate	the	coupling	with	NED	(Scheme	
2)	 leading	 to	 enhanced	 sensitivity	 and	 improved	 detection	
limits.	 Moreover,	 the	 relative	 resonance	 stabilization	 of	 the	
diazonium	salt	is	predicted	to	hasten	the	diazotization	step	via	
the	intermediacy	of	a	resonance‐stabilized	species	(Scheme	2).	
The	 release	 of	 NO	 from	 the	 prepared	 compounds	 was	
measured	 on	 the	 basis	 of	 the	 produced	 nitrite,	 which	 is	 a	
convenient	index	of	nitric	oxide	production.	In	this	context,	the	
newly	 proposed	 Griess	 modification	 was	 first	 validated	 by	
constructing	 a	 standard	 sodium	 nitrite	 curve	 obtained	 by	
measuring	the	absorbance	of	various	concentrations	of	sodium	
nitrite	solution.	Initially,	sodium	nitrite	solutions	were	treated	
with	 a	 solution	 of	 4‐nitroaniline	 to	 form	 the	 diazonium	 slat	
followed	by	treating	the	resultant	diazonium	salt	with	NED	to	
afford	 the	purple	azo	dye	 that	was	measured	at	max	539	nm.	
We	 were	 delighted	 to	 find	 the	 short	 time	 needed	 for	 the	
diazocoupling	 process;	 the	 overall	 reaction	 time	 was	 10	
minutes	 beyond	 which	 a	 stable	 plateau	 absorbance	 was	
achieved	 (Figure	 2).	 Conversely,	 the	 classical	 Griess	 method	
usually	 requires	 longer	 time	 (30	minutes)	 for	 completing	 the	
reaction.	
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Table	1.	Comparison	of	the	analytical	parameters	to	validate	the	proposed	method.	
Parameters	 Conventional	Griess	method	(using	sulfanilamide)	 Newly	modified	method	(using	4‐nitroaniline)	
Concentration	range	(µg/mL) 100‐6.25	 25‐0.39
Intercept 0.1495	 0.145
Correlation	coefficient	(r2)	 0.999	 0.998
Limit	of	detection	(µg/mL)	 3.125	 0.39
Limit	of	quantitation	(µg/mL)	 6.25	 0.78	
Reaction	time	(minutes)	 30	 10	
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Figure	2.	Effect	of	time	on	the	absorbance	of	reaction	product	of	nitrite	with	
the	modified	Griess	reagent.	
	
Moreover,	 the	 newly	 modified	 method	 showed	 an	
excellent	 reproducibility	 and	 linearity	 of	 the	 standard	 nitrite	
curve	particularly	at	submicromolar	concentrations	(Table	1).	
A	 detection	 limit	 of	 0.39	 μM	 was	 realized	 suggesting	 the	
reliable	 sensitivity	 of	 the	 new	method	 in	 comparison	 to	 the	
classical	 one	 in	 which	 the	 sensitivity	 for	 the	 nitrite	
concentrations	below	3.125	μM	was	markedly	reduced	(Table	
1).	These	outcomes	suggest	that	the	newly	developed	method	
would	 pave	 the	way	 for	 potential	 applications	 in	 the	 precise	
determination	of	nitrite	 levels	 in	water	or	biological	 fluids	or	
even	foodstuffs.	
Motivated	by	the	above‐mentioned	results,	we	applied	the	
new	 method	 to	 estimate	 the	 NO	 release	 from	 NO	 donor	
hybrids	3	and	7.	The	reaction	was	carried	out	in	the	presence	
of	N‐acetylcysteine	as	a	source	of	thiol	to	facilitate	the	release	
of	NO	from	the	compounds.	The	NO	release	was	measured	at	
100	μM	concentration	of	 the	 tested	compounds	and	assessed	
in	 the	 stable	 nitrite	 form	 relative	 to	 that	 of	 standard	 sodium	
nitrite	 solution	 and	 calculated	 as	 amount	 of	 NO	 released	
(mol/mol)	 as	 shown	 in	 Figure	 3.	 The	 results	 indicated	 that	
oxime	7	and	nitrate	ester	3	had	the	ability	to	release	NO,	albeit	
in	low	amounts;	9	and	5	μM,	respectively,	as	maximum	release	
after	 30	minutes.	 In	 contrast,	 the	 classical	Griess	method	did	
not	allow	the	detection	of	measurable	amounts	of	NO	released	
from	 our	 compounds.	 This	 could	 probably	 be	 explained	 by	
considering	a	faster	coupling	rate	between	NED	and	the	highly	
electrophilic	4‐nitroaniline	diazonium	salt	in	our	new	method	
in	comparison	to	 the	relatively	slower	reaction	between	NED	
and	sulphanilamide	diazonium	salt	in	the	conventional	method.		
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Figure	 3.	NO	 release	 from	 compounds	 3	 and	 7	 by	 the	 newly	 developed	
Griess	method.	
	
4.	Conclusion	
	
New	norfloxacin/NO	donor	hybrids	were	synthesized	and	
characterized	 by	 various	 spectroscopic	 tools.	 The	NO	 release	
from	 the	 target	 compounds	 was	 estimated	 by	 a	 modified	
Griess	 method	 in	 which	 4‐nitroaniline	 was	 used	 instead	 of	
sulfanilamide.	 The	 modified	 method	 led	 to	 a	 faster	 reaction	
and	 improved	 sensitivity	 for	 nitrite	 determination	 in	
comparison	 to	 the	 classical	 method.	 Despite	 the	 modest	 NO	
release	from	our	synthesized	hybrids,	it	is	anticipated	that	the	
new	 protocol	 would	 find	 great	 potential	 for	 the	 analysis	 of	
nitrites	in	various	systems.	
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